These findings indicate that transcriptional alterations induced by ATRX deficiency in cultured mNPCs at least partially recapitulate those occurring in ATRX-mutant gliomas, while also implicating cellular developmental programing in the mediation of this biology. This evidence concerns the gene ATRX and central nervous system cancer.